CXCL12 and IGF1 select for cancer cell populations with enhanced bone metastasis ability
Ontology highlight
ABSTRACT: CXCL12 and IGF1 confer on cancer cells survival advantage. Src potentiates cancer cells' reponse to CXCL12 and IGF1 by strengthening AKT activation. Long-term incubation of CXCL12 and IGF1 select for cancer cells with enhanced Src activity and bone metastasis potential. MDA-MB-231 cells were incubated for three weeks in growth medium of reduced serum concentration (0.2%) with or without CXCL12 (30 ng/ml) and IGF1 (10 ng/ml). Cell populations survive under these condidtions are expanded by regular growth medium with 10% serum. Two biological replicates were profiled for each condition.
ORGANISM(S): Homo sapiens
SUBMITTER: Xiang Zhang
PROVIDER: E-GEOD-39102 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA